BB Biotech Ventures

BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices.

Business Model:

Revenue: $10.7M

Employees: 2-10

Rankings

Detailed BB Biotech Ventures Information

Geographic Data

BB Biotech Ventures headquarters map

Address: Seestrasse 16

City:

State: zurich

Zip: 8700

Country: CH

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernsey–based fund is advised by the Bellevue Asset Management Group, which has operations in Curaçao, Boston/USA and Kusnacht/Zurich, Switzerland. BB BIOTECH VENTURES has a dedicated team of investment advisors and an advisory board. In addition, it is supported by all of the Group’s health care investment experts, and an extensive network of specialists and advisors. Our goal is to maximize the returns to our investors. To achieve this goal, we combine hard working, experience, networking, and focus on value creation.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
4/2009 Orthocon Series B 25M
6/2014 Natural Dental Implants Series A 1.4M
8/2007 Pevion Biotech Series A 29.2M
1/2014 Sonetik Series A -
4/2009 Aerovance Venture Round 38M
4/2013 Radius Health Private Equity Round 43M
8/2007 Alpex Pharma Series B 9M
11/2003 Auxilium Pharmaceuticals Series D 43M
2/2008 BioVascular Series C 10.9M
12/2019 Aleva Neurotherapeutics Series E 8.1M
12/2016 Abyrx Venture Round 0
9/2011 AM Pharma Series D 39.9M
9/2014 AM Pharma Series E 15.8M
8/2009 Palyon Medical Series A 24M
2/2010 Tioga Pharmaceuticals Venture Round 18M
2/2006 Orthocon Series A 10M
9/2005 TargeGen Series C 30M
12/2005 Optimer Pharmaceuticals Series D 22.2M
1/2006 Tioga Pharmaceuticals Series A 24M
10/2013 Opsona Series C 0
11/2009 Vivoryon Therapeutics Series B 0
1/2012 Vivoryon Therapeutics Venture Round 19.4M
4/2007 Radius Health Series B 57.5M
3/2006 BioXell Series C 12.7M
4/2013 Opsona Series C 0
1/2017 Binx Health Series D 0
1/2015 Binx Health Series C 0
7/2011 Binx Health Series B 27.1M
8/2001 Eyetech Pharmaceuticals Series C 108.5M
12/2011 Radius Health Private Equity Round 21.4M
7/2011 Radius Health Series C 66M
11/2008 Radius Health Series C 15M
4/2012 Aleva Neurotherapeutics Series B 4.4M
10/2004 BioXell Series C 29M
9/2022 Rivus Pharmaceuticals Series B 132M
12/2009 Molecular Partners Series B 44.2M
1/2011 VAXIMM Venture Round 8M
8/2007 Molecular Partners Series A 15.6M
4/2014 Binx Health Series B 0
3/2020 AM Pharma Venture Round 25.4M
2/2018 Moderna Therapeutics Series G 0
8/2011 Aleva Neurotherapeutics Series A 13.7M
5/2016 Aleva Neurotherapeutics Series C 18M
9/2008 Lumavita Series A 16.2M
7/2007 TargeGen Series D 40M
3/2020 AM Pharma Venture Round 0
12/2019 Aleva Neurotherapeutics Series E 0
2/2018 Moderna Therapeutics Series G 0
1/2017 Binx Health Series D 0
12/2016 Abyrx Venture Round 0
5/2016 Aleva Neurotherapeutics Series C 0
1/2015 Binx Health Series C 0
9/2014 AM Pharma Series E 0
6/2014 Natural Dental Implants Series A 0
4/2014 Binx Health Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research